Update on mechanisms of ischemic acute kidney injury

Journal of the American Society of Nephrology

Volumn 17, Issue 6, 2006, Pages 1503-1520

  Devarajan, Prasad ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA INTERMEDIN; APOTRANSFERRIN; BONE MORPHOGENETIC PROTEIN; CASPASE INHIBITOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; CREATININE; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; HEAT SHOCK PROTEIN 72; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LIPOCALIN; LIPOSOME; MINOCYCLINE; MONOCLONAL ANTIBODY; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NORPHENAZONE; OROSOMUCOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; RECEPTOR BLOCKING AGENT; SCATTER FACTOR; STATINE DERIVATIVE; TEPRENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY INJURY; ACUTE KIDNEY TUBULE NECROSIS; APOPTOSIS; CELL METABOLISM; CELL PROTECTION; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG MECHANISM; EARLY DIAGNOSIS; ERYTHROPOIESIS; GENE EXPRESSION; GENE THERAPY; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY STRUCTURE; KIDNEY TUBULE; KIDNEY TUBULE CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASOCONSTRICTION;

EID: 33744944269     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006010017     Document Type: Review

References (208)

1. Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 365: 417-430, 2005
2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004
3. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813-818, 2005
4. American Society of Nephrology Renal Research Report. J Am Soc Nephrol 16: 1886-1903, 2005
5. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
6. Mehta RL, Chertow GM: Acute renal failure definitions and classification: Time for change? J Am Soc Nephrol 14: 2178-2187, 2003
7. Warnock DG: Towards a definition and classification of acute kidney injury. J Am Soc Nephrol 16: 3149-3150, 2005
8. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004
9. Safirstein RL: Acute renal failure: From renal physiology to the renal transcriptome. Kidney Int 66: S62-S66, 2004
10. Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P: Activation of mitochondrial apoptotic pathways in human renal allografts following ischemia-reperfusion. Transplantation 76: 50-54, 2003
11. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 364: 1814-1827, 2004
12. Racusen LC: The morphologic basis of acute renal failure. In: Acute Renal Failure, edited by Molitoris BA, Finn WF, Philadelphia, W.B. Saunders, 2001, pp 1-12
13. Bonventre JV, Zuk A: Ischemic acute renal failure: An inflammatory disease? Kidney Int 66: 480-485, 2004
14. Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-490, 2004
15. Molitoris BA, Sutton TA: Endothelial injury and dysfunction: Role in the extension phase of acute renal failure. Kidney Int 66: 496-499, 2004
16. Dagher PC, Herget-Rosenthal S, Ruehm SG, Jo S-K, Star RA, Agarwal R, Molitoris BA: Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol 14: 2188-2198, 2003
17. Goligorsky MS: Whispers and shouts in the pathogenesis of acute renal ischaemia. Nephrol Dial Transplant 20: 261-266, 2005
18. Jerkic M, Miloradovic Z, Jovovic D, Mihailovic-Stanojevic N, Elena JV, Nastic-Miric D, Grujic-Adanja G, Rodriguez-Barbero A, Markovic-Lipkovski J, Vojvodic SB, Manero MV, Prieto MP, Lopez-Novoa JM: Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure. Nephrol Dial Transplant 19: 83-94, 2004
19. Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, Nalesnik MA, Otterbein LE, Murase N: Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 287: F979-F989, 2004
20. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE: Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 16: 950-958, 2005
21. Lameire NH, De Vriese AS, Vanholder R: Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care 9: 481-490, 2003
22. Wangsiripaisan A, Gengaro PE, Edelstein CL, Schrier RW: Role of polymeric Tamm-Horsfall protein in cast formation: Oligosaccharide and tubular fluid ions. Kidney Int 59: 932-940, 2001
23. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL: High-Dose Furosemide in Acute Renal Failure Study Group: High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 44: 402-409, 2004
24. Gambaro G, Bertaglia G, Puma G, D'Angelo A: Diuretics and dopamine for the prevention and treatment of acute renal failure: A critical reappraisal. J Nephrol 15: 213-219, 2002
25. Kwon O, Corrigan G, Myers BD, Sibley R, Scandling JD, Dafoe D, Alfrey E, Nelson WJ: Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. Kidney Int 55: 963-975, 1999
26. Schnermann J: Homer W. Smith Award lecture. The juxtaglomerular apparatus: From anatomical peculiarity to physiological relevance. J Am Soc Nephrol 14: 1681-1694, 2003
27. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW: A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 286: F298-F306, 2004
28. Devarajan P: Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17: 193-199, 2005
29. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP: A trial of thyroxine in acute renal failure. Kidney Int 57: 293-298, 2000
30. Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Greenberg A, Johnson JP: Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant. 2: 57-61, 2002
31. Cheng C-W, Rifai A, Ka S-M, Shui H-A, Lin Y-F, Lee W-H, Chen A: Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 68: 2694-2703, 2005
32. Shilliday IR, Sherif M: Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 1: CD003421, 2004
33. Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA; The PICARD Group: Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15: 2449-2456, 2004
34. Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E: Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65: 1714-1723, 2004
35. Dragsten PR, Hallaway PE, Hanson GJ, Berger AE, Bernard B, Hedlund BE: First human studies with a high-molecular-weight iron chelator. J Lab Clin Med 135: 57-65, 2000
36. de Vries B, Walter SJ, Bonsdorff LV, Wolfs TG, van Heurn LW, Parkkinen J, Buurman WA: Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 77: 669-675, 2004
37. Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J: Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Br J Haematol 119: 547-553, 2002
38. Mishra J, Qing M, Prada A, Zahedi K, Yang Y, Barasch J, Devarajan P: Identification of NGAL as a novel early urinary marker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003
39. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): A novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24: 307-315, 2004
40. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15: 3073-3082, 2004
41. Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621, 2005
42. Molitoris BA: Actin cytoskeleton in ischemic acute renal failure. Kidney Int 66: 871-883, 2004
43. Ashworth SL, Sandoval RM, Horsford M, Bamburg JR, Molitoris BA: Ischemic injury induces ADF relocalization to the apical domain of rat proximal tubule cells. Am J Physiol Renal Physiol 280: F886-F894, 2001
44. Ashworth SL, Southgate EL, Sandoval RM, Meberg PJ, Bamburg JR, Molitoris BA: ADF/cofilin mediates actin cytoskeletal alterations in LLC-PK cells during ATP depletion. Am J Physiol Renal Physiol 284: F852-F862, 2003
45. Ashworth SL, Wean SE, Campos SB, Temm-Grove CJ, Southgate EL, Vrhovski B, Gunning P, Weinberger RP, Molitoris BA: Renal ischemia induces tropomyosin dissociation-destabilizing microvilli microfilaments. Am J Physiol Renal Physiol 286: F988-F996, 2004
46. Huang TY, Dermardirossian C, Bokoch GM: Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol 18: 26-31, 2006
47. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, Li P: Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 5: 1083-1089, 2003
48. Lee DBN, Huang E, Ward HJ: Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290: F20-F34, 2006
49. Kwon O, Nelson WJ, Sibley R, Huie P, Scandling JD, Dafoe D, Alfrey E, Myers BD: Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J Clin Invest 101: 2054-2064, 1998
50. Woroniecki R, Ferdinand JR, Morrow JS, Devarajan P: Dissociation of the spectrin-ankyrin complex as a basis for loss of Na,K-ATPase polarity after ischemia. Am J Physiol Renal Physiol 284: F358-F364, 2003
51. Horton MA: Arg-Gly-Asp (RGD) peptides and peptidomimetics as therapeutics: Relevance for renal diseases. Exp Nephrol 7: 178-184, 1999
52. Molina A, Ubeda M, Escribese MM, Garcia-Bermejo L, Sancho D, de Lema GP, Liano F, Cabanas C, Sanchez-Madrid F, Mampaso F: Renal ischemia/reperfusion injury: Functional tissue preservation by anti-activated beta1 integrin therapy. J Am Soc Nephrol 16: 374-382, 2005
53. Saikumar P, Venkatachalam MA: Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 6: 512-521, 2003
54. Kaushal GP, Basnakian AG, Shah SV: Apoptotic pathways in ischemic acute renal failure. Kidney Int 66: 500-505, 2004
55. Dagher PC: Apoptosis in ischemic renal injury: Roles of GTP depletion and p53. Kidney Int 66: 506-509, 2004
56. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63: 1714-1724, 2003
57. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC: P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: Protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138, 2003
58. Del Rio M, Imam A, DeLeon MG, Mishra J, Ma Q, Parikh S, Devarajan P: The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol 15: 41-51, 2004
59. de Vries B, Walter SJ, Wolfs TG, Hochepied T, Rabina J, Heeringa P, Parkkinen J, Libert C, Buurman WA: Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis. Transplantation 78: 1116-1124, 2004
60. Chatterjee PK, Todorovic Z, Sivarajah A, Mota-Filipe H, Brown PAJ, Stewart KN, Cuzzocrea S, Thiemermann C: Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney. Eur J Pharmacol 503: 173-183, 2004
61. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A 101: 14883-14888, 2004
62. Kelly KJ, Sutton TA, Weathered N, Ray N, Caldwell EJ, Plotkin Z, Dagher PC: Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J Physiol Renal Physiol 287: F760-F766, 2004
63. Wei Q, Alam MM, Wang M-H, Wang MH, Yu F, Dong Z: Bid activation in kidney cells following ATP depletion in vitro and ischemia in vivo. Am J Physiol Renal Physiol 286: F803-F809, 2004
64. Lee HT, Gallos G, Nasr SH, Emala CW: A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 15: 102-111, 2004
65. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19: 348-355, 2004
66. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP, Heudes D, Wahli W, Desvergne B, Baud L: Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 16: 2395-2402, 2005
67. Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Miki Y, Kato S, Katsuno M, Sobue G, Yuzawa Y, Matsuo S: Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int 67: 2210-2220, 2005
68. Mizuno S, Nakamura T: Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 166: 1895-1905, 2005
69. Yang B, Jain S, Pawluczyk IZ, Imtiaz S, Bowley L, Ashra SY, Nicholson ML: Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats. Kidney Int 68: 2050-2067, 2005
70. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903, 2005
71. Zheng J, Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ: Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 288: F387-F398, 2005
72. Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ: Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure. Pharmacol Res 52: 44-59, 2005
73. Faubel S, Edelstein CL: Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5: 269-287, 2005
74. Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, Bevans S, Lentsch AB, Rabb H, Soleimani M: Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 115: 3451-3459, 2005
75. Villanueva S, Cespedes C, Vio CP: Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 290: R861-R870, 2005
76. Damianovich M, Ziv I, Heyman SN, Rosen S, Shina A, Kidron D, Aloya T, Grimberg H, Levin G, Reshef A, Bentolila A, Cohen A, Shirvan A: ApoSense: A novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 33: 281-291, 2006
77. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D: Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 21: 330-336, 2006
78. Takeda R, Nishimatsu H, Suzuki E, Satonaka H, Nagata D, Oba S, Sata M, Takahashi M, Yamamoto Y, Terauchi Y, Kadowaki T, Kangawa K, Kitamura T, Nagai R, Hirata Y: Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 17: 113-121, 2006
79. Wei Q, Yin XM, Wang MH, Dong Z: Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice. Am J Physiol Renal Physiol 290: F35-F42, 2006
80. Burns AT, Davies DR, McLaren AJ, Cerundolo L, Morris PJ, Fuggle SV: Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 66: 872-876, 1998
81. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10: 2006-2013, 1999
82. Schwarz C, Hauser P, Steininger R, Regele H, Heinze G, Mayer G, Oberbauer R: Failure of Bcl-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest 82: 941-948, 2002
83. Hoffman SC, Kampen RL, Amur S, Sharaf MA, Kleiner DE, Hunter K, John Swanson S, Hale DA, Mannon RB, Blair PJ, Kirk AD: Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 74: 916-923, 2002
84. Salahudeen AK, Huang H, Joshi M, Moore NA, Jenkins JK: Involvement of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant 3: 1-8, 2003
85. Hauser P, Schwarz C, Mitterbauer C, Regele HM, Muhlbacher F, Mayer G, Perco P, Mayer B, Meyer TW, Oberbauer R: Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 84: 353-361, 2004
86. Ortiz A, Justo P, Sanz A, Lorz C, Egido J: Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66: 1589-1594, 2003
87. Jani A, Ljubanivic D, Faubel SG, Edelstein CL: Caspase-3 and renal tubular cell death in cold preservation injury [Abstract]. J Am Soc Nephrol 14: 421A, 2003
88. Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC: Characterization of IDN-6556 (3-[2-(2-tert-butylphenylaminooxalyl)-amino]- propionylamino]-4-oxo-5-(2/3,5,6-tetrafluoro-phenoxy)-pentanoic acid): A liver-targeted caspase inhibitor. J Pharmacol Exp Ther 309: 634-640, 2004
89. Quadri SM, Segall L, de Perrot M, Ran B, Edwards V, Jones N, Waddell TK, Liu M, Keshavjee S: Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant 5: 292-299, 2005
90. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF: In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65: 834-845, 2004
91. Chatterjee PK, Chatterjee BE, Pedersen H, Sivarajah A, McDonald MC, Mota-Filipe H, Brown PA, Stewart KN, Cuzzocrea S, Threadgill MD, Thiemermann C: 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion. Kidney Int 65: 499-509, 2004
92. Aufricht C: HSP: Helper, suppressor, protector. Kidney Int 65: 739-740, 2004
93. Aufricht C: Heat-shock protein 70: Molecular supertool? Pediatr Nephrol 20: 707-713, 2005
94. Kelly KJ: Heat shock (stress response) proteins and renal ischemia/reperfusion injury. Contrib Nephrol 148: 86-106, 2005
95. Ruchalski K, Mao H, Singh SK, Wang Y, Mosser DD, Li F, Schwartz JH, Borkan SC: HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol 285: C1483-C1493, 2003
96. Meldrum KK, Burnett AL, Meng X, Misseri R, Shaw MB, Gearhart JP, Meldrum DR: Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-κB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92: 293-299, 2003
97. Riordan M, Garg V, Thulin G, Kashgarian M, Siegel NJ: Differential inhibition of HSP72 and HSP25 produces profound impairment of cellular integrity. J Am Soc Nephrol 15: 1557-1566, 2004
98. Riordan M, Sreedharan R, Wang S, Thulin G, Mann A, Stankewich M, Van Why S, Kashgarian M, Siegel NJ: HSP70 binding modulates detachment of Na-K-ATPase following energy deprivation in renal epithelial cells. Am J Physiol Renal Physiol 288: F1236-F1242, 2005
99. Pockley AG: Heat-shock proteins, anti-heat shock protein reactivity and allograft rejection. Transplantation 71: 1503-1507, 2001
100. Deyarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS: Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80: 365-376, 2003
101. Bonventre JV: Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14: 855-861, 2003
102. Hammerman MR: Recapitulation of phylogeny by ontogeny in nephrology. Kidney Int 57: 742-755, 2000
103. Yoshino J, Monkawa T, Tsuji M, Hayashi M, Saruta T: Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol 14: 3090-3101, 2003
104. Tanaka H, Terada Y, Kobayashi T, Okado T, Inoshita S, Kuwahara M, Seth A, Sato Y, Sasaki S: Expression and function of Ets-1 during experimental acute renal failure in rats. J Am Soc Nephrol 15: 3083-3092, 2004
105. Terada Y, Tanaka H, Sasaki S: Wnt-4 and Ets-1 signaling pathways for regeneration after acute renal failure. Kidney Int 68: 1969, 2005
106. Devarajan P: Has HGF met other partners? Met-independent epithelial morphogenesis induced by HGF. Am J Physiol Cell Physiol 286: C475-C477, 2004
107. Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, Esbrit P, Orloff JJ, Garcia-Ocana A: Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: The efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 15: 112-125, 2004
108. Fernandez M, Medina A, Santos F, Carbajo E, Rodriguez J, Alvarez J, Cobo A: Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. J Am Soc Nephrol 12: 1900-1907, 2001
109. Hladunewich MA, Corrigan G, Derby GC, Ramaswamy D, Kambham N, Scandling JD, Myers BD: A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF. Kidney Int 64: 593-602, 2003
110. Gupta S, Verfaillie C, Chmielewski D, Kim Y, Rosenberg ME: A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62: 1285-1290, 2002
111. Poulsom R, Alison MR, Cook T, Jeffery R, Ryan E, Forbes SJ, Hunt T, Wyles S, Wright NA: Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol 14[Suppl 1]: S48-S54, 2003
112. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, Igarashi P: Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14: 1188-1199, 2003
113. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG: Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112: 42-49, 2003
114. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G: Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15: 1794-1804, 2004
115. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C: Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68: 1613-1617, 2005
116. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, Bonventre JV: Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115: 1743-1755, 2005
117. Krause D, Cantley LG: Bone marrow plasticity revisited: Protection or differentiation in the kidney tubule? J Clin Invest 115: 1705-1708, 2005
118. Lin F, Moran A, Igarashi P: Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115: 1756-1764, 2005
119. Stokman G, Leemans JC, Claessen N, Weening JJ, Florquin S: Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol 16: 1684-1692, 2005
120. Duffield JS, Bonventre JV: Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68: 1956-1961, 2005
121. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q: The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114: 795-804, 2004
122. Haller H, de Groot K, Bahlmann F, Elger M, Fliser D: Stem cells and progenitor cells in renal disease. Kidney Int 68: 1932-1936, 2005
123. Maeshima A, Sakurai H, Nigam SK: Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 17: 188-198, 2006
124. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-F42, 2005
125. Rabb H: Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney. Am J Physiol Renal Physiol 289: F29-F30, 2005
126. Kwon O, Phillips CL, Molitoris BA: Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiol Renal Physiol 282: F1012-F1019, 2002
127. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA: Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285: F191-F198, 2003
128. Vallet B: Bench-to-bedside review: Endothelial cell dysfunction in severe sepsis: A role in organ dysfunction? Crit Care 7: 130-138, 2003
129. Yamamoto T, Tada T, Brodsky SV, Tanaka H, Noiri E, Kajiya F, Goligorsky MS: Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 282: F1150-F1155, 2002
130. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, Goligorsky MS: Endothelial dysfunction in ischemic acute renal failure: Rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002
131. Basile DP, Fredrich K, Weihrauch D, Hattan N, Chilian WM: Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 286: F893-F902, 2004
132. Singbartl K, Ley K: Leukocyte recruitment and acute renal failure. J Mol Med 82: 91-101, 2004
133. Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, Issekutz A, Kasiske BL, Keane WF, Rabb H: Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 60: 2205-2214, 2001
134. Burne MJ, Rabb H: Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. J Immunol 169: 2648-2652, 2002
135. Singbartl K, Forlow SB, Ley K: Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 15: 2337-2344, 2001
136. Roelofs JJ, Rouschop KM, Leemans JC, Claessen N, de Boer AM, Frederiks WM, Lijnen HR, Weening JJ, Florquin S: Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol 17: 131-140, 2006
137. Ramesh G, Reeves WB: Inflammatory cytokines in acute renal failure. Kidney Int Suppl 91: S56-S61, 2004
138. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY: Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16: 3315-3325, 2005
139. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA; PICARD Study Group: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65: 1357-1365, 2004
140. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ: Elevation of CXCR3-binding chemokines in urine indicates acute renal allograft dysfunction. Am J Transplant 4: 432-437, 2004
141. Gould SE, Day M, Jones SS, Dorai H: BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61: 51-60, 2002
142. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O K: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 62: 1160-1170, 2002
143. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H: CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14: 2503-2515, 2003
144. Day YJ, Huang L, Ye H, Linden J, Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005
145. Yokota N, Daniels F, Crosson J, Rabb H: Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 74: 759-763, 2002
146. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H: Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285: F87-F94, 2003
147. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, De Broe ME: T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66: 491-496, 2004
148. Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, Keane W, Tang WW: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000
149. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290, 2001
150. Yokota N, Burne-Taney M, Racusen L, Rabb H: Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 285: F319-F325, 2003
151. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ: Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 282: F352-F357, 2002
152. Faubel S, Ljubanovic D, Poole B, Dursun B, He Z, Cushing S, Somerset H, Gill RG, Edelstein CL: Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation 80: 643-649, 2005
153. Burne-Taney MJ, Ascon DB, Daniels F, Racusen L, Baldwin W, Rabb H: B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171: 3210-3215, 2003
154. Quigg RJ: Complement and the kidney. J Immunol 171: 3319-3324, 2003
155. Ward PA: The dark side of C5a in sepsis. Nat Rev Immunol 4: 133-142, 2004
156. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM: The role of the complement system in ischemia-reperfusion injury. Shock 21: 401-409, 2004
157. Guo RF, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821-852, 2005
158. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM: Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170: 1517-1523, 2003
159. Thurman JM, Lucia MS, Ljubanovic D, Holers VM: Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 67: 524-530, 2005
160. Holers VM, Thurman JM: The alternative pathway of complement in disease: Opportunities for therapeutic targeting. Mol Immunol 41: 147-152, 2004
161. de Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA: The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 165: 1677-1688, 2004
162. Moller-Kristensen M, Wang W, Ruseva M, Thiel S, Nielsen S, Takahashi K, Shi L, Ezekowitz A, Jensenius JC, Gadjeva M: Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 61: 426-434, 2005
163. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363-1371, 2000
164. Yamada K, Miwa T, Liu J, Nangaku M, Song WC: Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172: 3869-3875, 2004
165. Fayyazi A, Scheel O, Werfel T, Schweyer S, Oppermann M, Gotze O, Radzun HJ, Zwirner J: The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 99: 38-45, 2000
166. de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170: 3883-3889, 2003
167. Riedemann NC, Guo RF, Neff TA, Laudes IJ, Keller KA, Sarma VJ, Markiewski MM, Mastellos D, Strey CW, Pierson CL, Lambris JD, Zetoune FS, Ward PA: Increased C5a receptor expression in sepsis. J Clin Invest 110: 101-108, 2002
168. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA: Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 75: 375-382, 2003
169. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM: A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63: 134-142, 2003
170. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P,
171. Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, Thiemermann C: Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312: 1170-1178, 2005
172. Langer R, Wang M, Stepkowski SM, Hancock WW, Han R, Li P, Feng L, Kirken RA, Berens KL, Dupre B, Podder H, Dixon RA, Kahan BD: Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. J Am Soc Nephrol 15: 2893-2901, 2004
173. Mozaffarian D, Minami E, Letterer RA, Lawler RL, McDonald GB, Levy WC: The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol 96: 1699-1704, 2005
174. Elrod JW, Lefer DJ: The effects of statins on endothelium, inflammation and cardioprotection. Drug News Perspect 18: 229-236, 2005
175. Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi Y: Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 20: 133-136, 2005
176. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13: 2288-2298, 2002
177. Yokota N, O'Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B, Rabb H: Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 23: 13-17, 2003
178. Sabbatini M, Pisani A, Uccello F, Serio V, Seru R, Paterno R, Cianciaruso B, Fuiano G, Andreucci M: Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 15: 901-909, 2004
179. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100: 4802-4806, 2003
180. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, FrokiAEr J, Nielsen S: EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66: 683-695, 2004
181. Deng J, Hu X, Yuen PS, Star RA: Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 169: 749-756, 2004
182. Kurella M, Hsiao LL, Yoshida T, Randall JD, Chow G, Sarang SS, Jensen RV, Gullans SR: DNA microarray analysis of complex biologic processes. J Am Soc Nephrol 12: 1072-1078, 2001
183. Higgins JP, Wang L, Kambham N, Montgomery K, Mason V, Vogelmann SU, Lemley KV, Brown PU, Brooks J LJ, van de Rijn M: Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell 15: 649-656, 2004
184. Schwab K, Patterson LT, Aronow BJ, Luckas R, Liang HC, Potter SS: A catalogue of gene expression in the developing kidney. Kidney Int 64: 1588-1604, 2003
185. Liang M, Cowley AW Jr, Hessner MJ, Lazar J, Basile DP, Pietrusz JL: Transcriptome analysis and kidney research: Toward systems biology. Kidney Int 67: 2114-2122, 2005
186. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998
187. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 37-244, 2002
188. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV: Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277: 39739-39748, 2002
189. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290: F517-F529, 2006
190. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, Devarajan P: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol March 10, 2006 [epub ahead of print]
191. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005
192. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J: An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056, 2002
193. Akagi R, Takahashi T, Sassa S: Cytoprotective effects of heme oxygenase in acute renal failure. Contrib Nephrol 148: 70-85, 2005
194. Gueler F, Gwinner W, Schwarz A, Haller H: Long-term effects of acute ischemia and reperfusion injury. Kidney Int 66: 523-527, 2004
195. Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A: The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286: F425-F441, 2004
196. Tarabishi R, Zahedi K, Mishra J, Ma Q, Kelly C, Tehrani K, Devarajan P: Induction of Zf9 in the kidney following early ischemia/reperfusion. Kidney Int 68: 1511-1519, 2005
197. Ren B, Yee KO, Lawler J, Khosravi-Far R: Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765: 178-188, 2005
198. Pagtalunan ME, Olson JL, Tilney NL, Meyer TW: Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 10: 366-373, 1999
199. Pagtalunan ME, Olson JL, Meyer TW: Contribution of angiotensin II to late renal injury after acute ischemia. J Am Soc Nephrol 11: 1278-1286, 2000
200. Forbes JM, Hewitson TD, Becker GJ, Jones CL: Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat. Kidney Int 57: 2375-2385, 2000
201. Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001
202. Basile DP, Donohoe DL, Roethe K, Mattson DL: Chronic renal hypoxia after acute ischemic injury: Effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338-F348, 2003
203. Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, Greene AS, Cowley AW Jr: Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288: F953-F963, 2005
204. Brady HR, Clarkson MR, Lieberthal W: Acute renal failure. In: Brenner and Rector's The Kidney, 7th Ed., edited by Brenner BM, Philadelphia, Saunders, 2004, pp 1215-1292
205. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002
206. Molitoris BA: Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14: 265-267, 2003
207. Schrier RW: Need to intervene in established acute renal failure. J Am Soc Nephrol 15: 2756-2758, 2004
208. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003